Trademark: 97728542
Word
B BIBO PHARMA
Status
Pending
Status Code
688
Status Date
Tuesday, December 26, 2023
Serial Number
97728542
Mark Type
3000
Filing Date
Thursday, December 22, 2022
Published for Opposition
Tuesday, October 31, 2023

Trademark Owner History
BiBo Pharma Scientific Co.,Ltd. - Owner At Publication

Classifications
5 Antivirals; Vaccines; Allergy relief medication; Anti-cancer preparations; Anti-diabetic preparations; Biological tissue cultures for medical purposes; Cultures of microorganisms for medical or veterinary use; Dietetic foods adapted for medical purposes; Fertility enhancement preparations; Medicinal hair growth preparations; Nutritional supplements; Pituitary hormone preparations; Probiotic supplements; Protein dietary supplements; Protein supplements for animals; Stem cells for medical purposes; Vaccines for horses; Veterinary vaccines; Yeast dietary supplements; Yeast extracts for medical, veterinary or pharmaceutical purposes; Yeast for medical, veterinary or pharmaceutical purposes; Yeast for pharmaceutical purposes
The mark consists of a lower case "b" shape formed by a green straight bar with three crescents with two in green and one in blue and the stylized wording "BiBO Pharma" in blue on the right.
The color(s) green and blue is/are claimed as a feature of the mark.
"PHARMA"

Trademark Events
Dec 26, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 7, 2023
Assigned To Examiner
Oct 31, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 31, 2023
Published For Opposition
Oct 11, 2023
Notification Of Notice Of Publication E-Mailed
Sep 25, 2023
Approved For Pub - Principal Register
Sep 25, 2023
Examiner's Amendment Entered
Sep 25, 2023
Notification Of Examiners Amendment E-Mailed
Sep 25, 2023
Examiners Amendment E-Mailed
Sep 25, 2023
Examiners Amendment -Written
Sep 22, 2023
Assigned To Examiner
Jan 20, 2023
Notice Of Design Search Code E-Mailed
Jan 19, 2023
New Application Office Supplied Data Entered
Dec 26, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24